(Q37278993)

English

Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression

scientific article published on September 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Núria Malats

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

1 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Scandinavian Journal of Urology and Nephrology. Supplement

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

218

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

131-140

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Screening for bladder cancer: a perspective

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk?

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Familial aggregation of urothelial cell carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphism in bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

GSTP1 A1578G (Ile105Val) polymorphism in benzidine-exposed workers: an association with cytological grading of exfoliated urothelial cells

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

GSTT1-null genotype is a protective factor against bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

No association between SOD2 or NQO1 genotypes and risk of bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

An association between NQO1 genetic polymorphism and risk of bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

CYP1A2 activity as a risk factor for bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

CYP2E1 and NQO1 genotypes, smoking and bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms in DNA repair and metabolic genes in bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

p53 codon 72 polymorphism and its association with bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

p21 gene codon 31 polymorphism is associated with bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

A case-control study of cyclin D1 CCND1 870A-->G polymorphism and bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Lack of evidence for the association of tumor necrosis factor-alpha gene promoter polymorphism with calcium oxalate stone and bladder cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer?

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Association Between A C/A Single Nucleotide Polymorphism of the E-Cadherin Gene Promoter and Transitional Cell Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

HRAS1 variable number of tandem repeats polymorphism and risk of bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Influence of GSTM1, GSTT1, GSTP1 and NAT2 genotypes on the p53 mutational spectrum in bladder tumours

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

The road to genome-wide association studies

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Familial Transitional Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic variation in the base excision repair pathway and bladder cancer risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Clinical course of bladder neoplasms and single nucleotide polymorphisms in theCDKN2Agene

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

When the smoke clears ..

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Identifiers

10.1080/03008880802285172

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37278993&oldid=2180028304"